Lv63
1650 积分 2024-12-16 加入
Glucose disappearance rate in rhesus monkeys: Some technical considerations
12天前
已完结
Discovery of RGT-018: A Potent, Selective, and Orally Bioavailable SOS1 Inhibitor for KRAS-Driven Cancers
25天前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
26天前
已完结
First-in-class YAP/TEAD Inhibitor Shows Promise in Hippo-driven Mesothelioma
27天前
已关闭
Engineering of an Ultralong-Acting and Nonaggregating Dual Amylin and Calcitonin Receptor Agonist with Durable Efficacy in Obesity and Diabetes
1个月前
已完结
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
1个月前
已完结
Selective amylin receptor agonism: promise beyond incretins
1个月前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
2个月前
已完结
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wildtype RAS Activation in Non-Small Cell Lung Cancer
2个月前
已完结
皖公网安备34019202002308
